November 28
download app
download appDOWNLOAD OUR APP
download google-play
download app-store
Dolores Utrilla
22nd September 2021
Consumer, Health & Environment Covid-19 Institutional law Internal Market

Commission signs contract for the supply of COVID-19 monoclonal antibody treatment

The European Commission has announced that it has signed a joint procurement framework contract with the pharmaceutical company Eli Lilly for the supply of a monoclonal antibody treatment for coronavirus patients, currently under rolling review by the European Medicines Agency (EMA).

The concerned medicine is a combination of two monoclonal antibodies (bamlanivimab and etesevimab) for the treatment of coronavirus patients who do not require oxygen but are at high risk of severe COVID-19. 18 Member States have signed up to the joint procurement for the purchase of up to 220,000 treatments, which will be possible once the medicine has received either a conditional marketing authorisation from EMA at EU level or an emergency use auth


Your privacy is important for us

We use cookies to improve the user experience. Please review privacy preferences.

Accept all Settings

Check our privacy policy and cookies policy.